Vaccines Bioprocess Development and Commercialisation (MBI® Training, Bioprocess Industries)
Course
In London
Description
-
Type
Course
-
Level
Intermediate
-
Location
London
-
Class hours
20h
-
Duration
3 Days
-
Start date
Different dates available
This three-day workshop will explore the critical issues at each stage of vaccine development.
You'll hear from international experts about the research, operational and regulatory challenges of the vaccine market.
The course is for research scientists, programme managers, process engineers and policy makers.
This workshop is being run by UCL in collaboration with Massachusetts Institute of Technology (MIT). It's part of the Modular Training for the Bioprocess Industries programme (MBI®), run by the Department of Biochemical Engineering at UCL.
Facilities
Location
Start date
Start date
About this course
By attending an MBI® course, you'll:
benefit from knowledge transfer and upskilling in core bioprocessing fundamentals and trends in industry
gain a deeper understanding of process options and engineering constraints
acquire the tools to optimise process performance and economics
learn about the latest technical and regulatory developments
have access to cutting edge research methodologies
network with sector leaders and subject matter experts
increase your flexibility, motivation, creativity and professional status
The course is for research scientists, programme managers, process engineers and policy makers.
It's suitable for:
those new to the vaccines sector (recent graduates/research scientists)
specialised vaccines staff who want to broaden their knowledge of vaccine technologies and platforms
project managers, funders and policy-makers wanting to gain an understanding of vaccines
Reviews
This centre's achievements
All courses are up to date
The average rating is higher than 3.7
More than 50 reviews in the last 12 months
This centre has featured on Emagister for 14 years
Subjects
- Bioprocess
- Bioprocess Development
- Commercialisation
- HIV vaccine
- Viral vaccines
- Human viral vaccines
- Project Management
- Legacy vaccines
- Manufacturing
- Clinical trial design
Course programme
Teaching is in small classes, with an emphasis on interactive problem solving and case studies.
Each day will cover the following topics:
Day 1- Challenges toward developing an HIV vaccine
- Development and case studies of recombinant vaccines
- Viral vaccines: manufacturing and development challenges
- Adjuvants and formulation
- The quality control of human viral vaccines
- Testing and control of adventitious agents
- Conjugate vaccines: Overview and challenges
- Analytical tools for 21st century vaccines
- Case study: vaccine commercialisation and project management - live influenza virus vaccine
- Bridging legacy vaccines
- Integrated and automated manufacturing
- New therapies based on the controlled modulation of the immune system
- Clinical trial design
- Vision for improved process development
Vaccines Bioprocess Development and Commercialisation (MBI® Training, Bioprocess Industries)